Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 46 AL 60

EP2 and EP4 in Alzheimer's Disease: Cell-Dependent Signalling and Implications for Selective Targeting

Zhao X, Zeng Y, Song Z, He J, He Q, Lin H, Liu L, Yu W, Cheng S.

Int J Mol Sci. 2026 Oct 16;27(20):9190. doi: 10.3390/ijms27209190.

Natural Compounds and Their Microbiota-Derived Metabolites as Modulators of the Microbiota-Gut-Brain Axis in Alzheimer Disease: Biochemical Mechanisms and Drug Discovery Insights-A Narrative Review

Cavalluzzi MM, Terlizzi F, Catalano A, Pannunzio A, Rotondo NP, Habtemariam S, Lentini G.

Molecules. 2026 Oct 17;31(20):3728. doi: 10.3390/molecules31203728.

The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective

Catakli D, Ozen-Basoglu O, Tuncgovde EB, Ozsarlak-Sozer G.

Basic Clin Pharmacol Toxicol. 2026 Oct;139(4):e70294. doi: 10.1111/bcpt.70294.

Progressive Amyloid-Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier

Stögmann E, Haider L, Leinkauf J, Nakuz T, Untersteiner H, Farr C, Silvaieh S, Parvizi T, Wurm R, Kasprian G, Berger T, Gelpi E, Sieczkowski EB.

Eur J Neurol. 2026 Oct;33(10):e70779. doi: 10.1111/ene.70779.

Intracranial metastasis as a mimic of amyloid-related imaging abnormalities

Hwang J, Delman BN, Naasan G.

Neurol Sci. 2026 Oct 15;47(11):856. doi: 10.1007/s10072-026-09449-8.

How can physicians empathetically deliver a diagnosis that reflects the evolving landscape of Alzheimer's disease care: A scoping review

Duhan A, Lu WH, Post S.

J Alzheimers Dis Rep. 2026 Oct 8;10:25424823261476636. doi: 10.1177/25424823261476636. eCollection 2026 Jan-Dec.

Real-World Patient Eligibility for Alzheimer's Disease Anti-Amyloid Therapy in Seven Swedish Memory Clinics

Rosenberg A, Rennie A, Ekman U, Daniilidou M, Hall A, Matton A, Solomon A, Wahlund LO, Kivipelto M, Westman E.

Eur J Neurol. 2026 Oct;33(10):e70786. doi: 10.1111/ene.70786.

Predicting cognitive function in Alzheimer's clinical trials via amyloid β-protein biomarkers

Sui Z, Feng A, Gong Y, Zha S, Lv Y, Zheng Q, Li L, Wang Y.

Br J Clin Pharmacol. 2026 Oct;92(10):3576-3585. doi: 10.1002/bcp.70665. Epub 2026 Jun 28.

Gingipains as macromolecular mediators at the periodontal-brain interface: Mechanistic, diagnostic, and therapeutic evidence in Alzheimer's and Parkinson's diseases

Dhar I, Gupta S, Mishra R, Dadhich A.

Int J Biol Macromol. 2026 Oct;377:153320. doi: 10.1016/j.ijbiomac.2026.153320. Epub 2026 Jul 2.

Plasma Biomarkers for Neocortical Tau Burden

Di Molfetta G, Brum WS, Pola I, Tan K, Benedet AL, Sauer M, Montoliu-Gaya L, Janelidze S, Mattsson-Carlgren N, Rahmouni N, Chan T, Denkinger MN, Proitsi P, Zetterberg H, Hansson O, Rosa-Neto P, Ashton NJ.

JAMA Neurol. 2026 Oct 1;83(10):990-1001. doi: 10.1001/jamaneurol.2026.2650.

Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases

Hwang J, Pietras A, Naasan G, Elahi FM, Gandy S.

Neurocase. 2026 Oct;32(5):229-232. doi: 10.1080/13554794.2026.2730462. Epub 2026 Sep 8.

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy

Benzinger TLS, Cogswell PM, Arani A, Chaney AM, Hutson K, Glasser MF, Graff-Radford J, McConathy J, Raji CA, Teunissen C, Vemuri P, Zaharchuk G, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):939-951. doi: 10.1016/S1474-4422(26)00285-1.

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change

Graff-Radford J, Karliner L, Barnes DE, Frisoni GB, Sperling R, Villain N, Benzinger TLS, Teunissen C, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):952-964. doi: 10.1016/S1474-4422(26)00248-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias